THE DEAL, AT A GLANCE
From the announcementSwiss biotech
01Who is involvedBacked by China 3698From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedSwiss biotech raised $152M Series B, announced 2026-08-13From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersSwiss biotech's $152M Series B is a large Healthcare & Life Sciences capital-flow signal within a sector that recorded 35 other trailing 30-day rounds totaling $2079M.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Swiss biotech · Financing Record
Explore source-linked visual explanations for Swiss biotech. Unsupported claims are withheld while source review continues.
Record 10175 · Recorded date: 2026-08-13
Explore company records →